These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [The combined effect of prenatal steroid prophylaxis, neonatal surfactant therapy and reduction of risk of complications from respiratory life support on survival rate of very low birthweight infants]. Görbe E; Jeager J; Kohalmi B; Patkós P; Cziniel M; Sassi L Orv Hetil; 2004 Jun; 145(23):1227-32. PubMed ID: 15264590 [TBL] [Abstract][Full Text] [Related]
9. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Ambalavanan N; Carlo WA Semin Perinatol; 2006 Aug; 30(4):192-9. PubMed ID: 16860159 [TBL] [Abstract][Full Text] [Related]
10. The evolution of neonatal respiratory distress syndrome into chronic lung disease. Robertson B Eur Respir J Suppl; 1989 Mar; 3():33s-37s. PubMed ID: 2742684 [TBL] [Abstract][Full Text] [Related]
11. Management of infants with bronchopulmonary dysplasia in North America. Bancalari E; Wilson-Costello D; Iben SC Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972 [TBL] [Abstract][Full Text] [Related]
12. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Garland JS; Buck RK; Allred EN; Leviton A Arch Pediatr Adolesc Med; 1995 Jun; 149(6):617-22. PubMed ID: 7767415 [TBL] [Abstract][Full Text] [Related]
16. Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence. Aly H Pediatrics; 2007 Apr; 119(4):818-20. PubMed ID: 17403854 [No Abstract] [Full Text] [Related]
17. Management of infants with chronic lung disease of prematurity in Chile. Palomino MA; Morgues M; Martínez F Early Hum Dev; 2005 Feb; 81(2):143-9. PubMed ID: 15748968 [TBL] [Abstract][Full Text] [Related]